These benefits, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the notion of focusing on ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. Importantly, these receptors were https://collinss059chl1.verybigblog.com/profile